US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents

Patent application publication

ATXN3 Gene - GeneCards, ATX3 Protein

WO2020006018A1 - Substituted naphthyridinone compounds useful as t cell activators - Google Patents

Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein - ScienceDirect

US20170175113A1 - Methods for modulating ataxin 2 expression - Google Patents

US10881730B2 - Immunomodulatory therapeutic MRNA compositions encoding activating oncogene mutation peptides - Google Patents

Ataxin 3 - an overview

High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression

ars.els-cdn.com/content/image/1-s2.0-S002192582040

US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents

Physiological and pathophysiological characteristics of ataxin-3 isoforms - ScienceDirect

ars.els-cdn.com/content/image/1-s2.0-S0021925820X6

US7612114B2 - Selective estrogen receptor modulator - Google Patents

US10442756B2 - Compounds and compositions for intracellular delivery of therapeutic agents - Google Patents

ATXN3 Gene - GeneCards, ATX3 Protein